CLGN
Collplant Biotechnologies LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$5.52M
P/E Ratio
—
EPS
$-0.94
Beta
0.94
52W High
$4.98
52W Low
$0.27
50-Day MA
$0.52
200-Day MA
$1.69
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
80.00
PEG Ratio
—
About Collplant Biotechnologies Ltd
CollPlant Biotechnologies Ltd., an aesthetic and regenerative medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. The company is headquartered in Rehovot, Israel.
Fundamentals
| Revenue (TTM) | $2.37M |
| Gross Profit (TTM) | $1.54M |
| EBITDA | $-10.57M |
| Operating Margin | -5250.00% |
| Return on Equity | -117.60% |
| Return on Assets | -48.70% |
| Revenue/Share (TTM) | $0.19 |
| Book Value | $0.47 |
| Price-to-Book | 0.88 |
| Price-to-Sales (TTM) | 2.33 |
| EV/Revenue | 1.086 |
| EV/EBITDA | -5.97 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -63.40% |
| Shares Outstanding | $14.42M |
| Float | $10.14M |
| % Insiders | 26.88% |
| % Institutions | 10.95% |
Analyst Ratings
Consensus ($11.12 target)
1
Buy1
HoldData last updated: 5/1/2026